96672 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
N-acyldipeptide derivatives and their uses
#2PEPTIDE-OLIGOUREA CHIMERIC COMPOUNDS AND METHODS OF THEIR USE
#3Compounds, linker-drugs and ligand-drug conjugates
#4Combination of N-acyldipeptide derivatives and retinol, and methods of use thereof
#5Compounds, linker-drugs and ligand-drug conjugates
#6Antibody-drug conjugate (ADC) and method for forming the same
#7N-acyldipeptide derivatives and their uses
#8Substrate-mimetic AKT inhibitor
#9Cyclic peptide compound, and preparation method, pharmaceutical composition and use thereof
#10Hydroxy-ethylene derivatives for the treatment of arthrosis
#11Potent and efficient cytotoxic peptides and antibody-drug conjugates thereof and their synthesis
#12Peptide-oligourea chimeric compounds and methods of their use
#13Substrate-mimetic Akt inhibitor
#14Inhibition of memapsin 1 cleavage in the treatment of diabetes
#15Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction
#16NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF
#17Methods of treating emesis using growth hormone secretagogues
#18Rapid FRET-based diagnosis of bacterial pathogens
#19Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#20γ-secretase inhibitor
#21COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF
#22HIV Protease Inhibiting Compounds
#23Organic Compounds and their uses
#24Substrate-mimetic Akt inhibitor
#25Anti-cancer compounds
#26Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#27Methods of treating emesis using growth hormone secretagogues
#28Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer's Disease II
#29Hemiasterlin Derivatives and Uses Thereof
#30Myd88 Homodimerization Inhibitors
#31Methods to Treat Alzheimer's Disease
#32Substituted sulfonamides and ureas useful for inhibiting kinase activity
#33Substituted sulfonamides and ureas useful for inhibiting kinase activity
#34Meta-benzamidine derivatives as serine protease inhibitors
#35Compounds to treat alzheimer's disease
#36Compounds to treat Alzheimer's disease
#37Beta-secretase inhibitors and methods of use
#38Gamma-secretase inhibitors
#39Anti-cancer compounds
#40Aza-peptide epoxides
#41Hemiasterlin derivatives and uses thereof
#42Beta-sheet breaker peptide analogs that inhibit beta-pleated sheet formation in amyloid beta-peptide
#43Low molecular weight peptidomimetic growth hormone secretagogues
#44Substituted ethane-1,2-diamines for the treatment of Alzheimer's disease
#45Compounds with growth hormone releasing properties
#46Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
#47HIV protease inhibiting compounds
#48Growth hormone secretagogues
#49Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#50Compounds which can block the response to chemical substances or thermal stimuli or mediators of inflammation of nociceptors, production method thereof and compositions containing same
#51Novel statine derivatives for the treatment of Alzheimer's disease